Cognivia is a pioneering organization that specializes in developing predictive tools to enhance the success of clinical trials. By integrating patient psychology with machine learning, Cognivia aims to reduce data variability and improve the predictability of patient responses in drug development. Their innovative solutions, such as Placebell, help mitigate issues like placebo response and patient heterogeneity, which are common challenges in clinical trials. Cognivia's approach focuses on understanding patient differences to increase trial success rates and expedite the delivery of new therapies to patients. With a strong background in clinical development and data science, Cognivia offers unique insights and technologies to support the biopharmaceutical industry